Post-COVID-19 SyndromeNCT07744451
Kinesiotaping Versus Physiotherapy for Post-Covid-19 Back Pain
A study testing Kinesiotaping and Conventional Physiotherapy in people with Post-COVID-19 Syndrome and Back Pain, run by Medipol University at 1 site in Turkey (Türkiye).
Trial summary
Objective: This study aims to compare and evaluate the effectiveness of kinesiotaping and traditional physiotherapy methods, which are frequently used in the treatment of musculoskeletal diseases, on mid-back pain (MBP) developed after COVID-19. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Post-COVID-19 Syndrome, Back Pain, Musculoskeletal Pain
- What is being tested?
- Kinesiotaping and Conventional Physiotherapy
- Type of treatment
- Medical device, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 33 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jan 2021to 11 Apr 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients aged 18 years and older.
- Patients experiencing mechanical mid-back pain (MBP) that developed after recovering from a confirmed COVID-19 infection.
- Volunteering to participate in the study and providing written informed consent.
Who cannot join
- History of previous spinal surgery or spinal trauma.
- Presence of structural spinal deformities (e.g., severe kyphosis or scoliosis).
- Presence of radicular pain, neurological deficits, or suspected disc herniation.
- Active infection, malignancy, or severe systemic inflammatory diseases.
- Known skin allergy or dermatological conditions preventing the application of Kinesio Tape.
- Pregnancy.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Istanbul Medipol University Pendik Hospital
Istanbul
About this study
Official title: A Comparison of the Efficiency of Physiotherapy and Kinesiotaping Treatments in the Treatment of Post-Covid-19 Back Pain
Objective:
This study aims to compare and evaluate the effectiveness of kinesiotaping and traditional physiotherapy methods, which are frequently used in the treatment of musculoskeletal diseases, on mid-back pain (MBP) developed after COVID-19.
Read more
Study Design and Methods:
Patients aged 18 or older who have been diagnosed with COVID-19, have completed their medical treatment, and whose isolation period has ended are included in the study. The patients' age, sex, and body mass index (BMI) are recorded.
The participants are assigned to receive one of two interventions. In the first group, kinesiotapes are applied and left on the patient's back for a total of 10 days. The second group is treated with traditional physiotherapy methods, specifically Vacuum Interferential Current Therapy and Hot Pack Therapy.
Clinical evaluations are performed using the Visual Analogue Scale (VAS), Pain Quality Assessment Scale, LANSS Neuropathic Pain Scale, and Nottingham Extended Activities of Daily Living Index. Measurements are taken at two time points: baseline (pre-treatment) and at the end of the 10th day (post-treatment).,
- Conditions
- Post-COVID-19 Syndrome, Back Pain, Musculoskeletal Pain
- Being tested
- Kinesiotaping, Conventional Physiotherapy
- Medical subject headings
- Post-Acute COVID-19 Syndrome, Back Pain, Musculoskeletal Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KinesiotapingDevice
Application of 5x5 cm Kinesio Tape with a slight stretch of approximately 10 to 15% on the painful back area during trunk flexion and contralateral rotation.
Conventional PhysiotherapyProcedure or surgery
Application of hot packs and vacuum interferential current therapy using diagonally placed vacuum electrodes (Intelect Mobile Combo®, USA) to encompass the pain area.
| Study group | Role | What they receive |
|---|---|---|
| Physiotherapy Group | Active comparator | Patients in this group received conventional physiotherapy, including 20 minutes of Hot Pack Therapy and 20 minutes of Vacuum Interferential Current Therapy (100 Hz). Daily sessions lasted 60 minutes and included home-based ROM and stretching exercises. Receives: Procedure: Conventional Physiotherapy |
| Kinesiotaping Group | Experimental | Patients in this group received Kinesio Tape (Kinesio® Tex Tape Gold) applied to the bilateral erector spinae muscles starting from the T12 vertebra level. The tape was renewed once every three days for a total treatment duration of 10 days. Receives: Device: Kinesiotaping |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Intensity assessed by Visual Analogue Scale (VAS)
The Visual Analogue Scale (VAS) is used to evaluate the patient's mid-back pain intensity under three conditions: at rest, at night, and during activity/exercise. The scale is a 10 cm line where 0 represents "no pain" and 10 represents "the worst imaginable pain." Higher scores indicate greater pain severity.
Measured: Baseline (Pre-treatment) and Day 10 (Post-treatment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Aug 2026
- Study start1 Jan 2021
- Primary completion11 Apr 2021
- Study completion11 Apr 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post-COVID-19 SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Eligible patients were randomly assigned to either the Kinesiotaping group or the Physiotherapy group in a 1:1 ratio for parallel interventions lasting 10 days
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 33 participants (actual)
Sponsor and investigators
- Lead sponsor
- Medipol University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Çağlayan Aslanbaş, Medipol University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07744451
- Sponsor's protocol ID
- MedipolU-961
- Status last verified
- Aug 2026
- First submitted
- 28 Jul 2026
- Last updated
- 4 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Comparison of the Efficiency of Physiotherapy and Kinesiotaping Treatments in the Treatment of Post-Covid-19 Back Pain
- ClinicalTrials.gov ID
- NCT07744451
- Acronym / sponsor ID
- MedipolU-961
- Conditions
- Post-COVID-19 Syndrome, Back Pain, Musculoskeletal Pain
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 33 participants (actual)
- Lead sponsor
- Medipol UniversityUniversity, hospital or other
- Study start
- 1 Jan 2021 (actual)
- Primary completion
- 11 Apr 2021 (actual)
- Study completion
- 11 Apr 2021 (actual)
- First posted
- 4 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective:
This study aims to compare and evaluate the effectiveness of kinesiotaping and traditional physiotherapy methods, which are frequently used in the treatment of musculoskeletal diseases, on mid-back pain (MBP) developed after COVID-19.
Study Design and Methods:
Patients aged 18 or older who have been diagnosed with COVID-19, have completed their medical treatment, and whose isolation period has ended are included in the study. The patients' age, sex, and body mass index (BMI) are recorded.
The participants are assigned to receive one of two interventions. In the first group, kinesiotapes are applied and left on the patient's back for a total of 10 days. The second group is treated with traditional physiotherapy methods, specifically Vacuum Interferential Current Therapy and Hot Pack Therapy.
Clinical evaluations are performed using the Visual Analogue Scale (VAS), Pain Quality Assessment Scale, LANSS Neuropathic Pain Scale, and Nottingham Extended Activities of Daily Living Index. Measurements are taken at two time points: baseline (pre-treatment) and at the end of the 10th day (post-treatment).,
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Eligible patients were randomly assigned to either the Kinesiotaping group or the Physiotherapy group in a 1:1 ratio for parallel interventions lasting 10 days
| Arm | Type | Receives |
|---|---|---|
| Physiotherapy Group | Active comparator | Procedure: Conventional PhysiotherapyPatients in this group received conventional physiotherapy, including 20 minutes of Hot Pack Therapy and 20 minutes of Vacuum Interferential Current Therapy (100 Hz). Daily sessions lasted 60 minutes and included home-based ROM and stretching exercises. |
| Kinesiotaping Group | Experimental | Device: KinesiotapingPatients in this group received Kinesio Tape (Kinesio® Tex Tape Gold) applied to the bilateral erector spinae muscles starting from the T12 vertebra level. The tape was renewed once every three days for a total treatment duration of 10 days. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patients aged 18 years and older.
- Patients experiencing mechanical mid-back pain (MBP) that developed after recovering from a confirmed COVID-19 infection.
- Volunteering to participate in the study and providing written informed consent.
Key exclusion criteria (6 listed)
- History of previous spinal surgery or spinal trauma.
- Presence of structural spinal deformities (e.g., severe kyphosis or scoliosis).
- Presence of radicular pain, neurological deficits, or suspected disc herniation.
- Active infection, malignancy, or severe systemic inflammatory diseases.
- Known skin allergy or dermatological conditions preventing the application of Kinesio Tape.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KinesiotapingApplication of 5x5 cm Kinesio Tape with a slight stretch of approximately 10 to 15% on the painful back area during trunk flexion and contralateral rotation. | Device | Kinesiotaping Group |
| Conventional PhysiotherapyApplication of hot packs and vacuum interferential current therapy using diagonally placed vacuum electrodes (Intelect Mobile Combo®, USA) to encompass the pain area. | Procedure or surgery | Physiotherapy Group |
Primary outcome
Pain Intensity assessed by Visual Analogue Scale (VAS)
Time frame: Baseline (Pre-treatment) and Day 10 (Post-treatment)
The Visual Analogue Scale (VAS) is used to evaluate the patient's mid-back pain intensity under three conditions: at rest, at night, and during activity/exercise. The scale is a 10 cm line where 0 represents "no pain" and 10 represents "the worst imaginable pain." Higher scores indicate greater pain severity.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Post-COVID-19 Syndrome
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruiting
Long COVID Brain Fog: Cognitive Rehabilitation Trial
Long COVID, Brain Fog
Recruiting
ME/CFS Brain Fog: Cognitive Rehabilitation Trial
ME/CFS, ME/CFS Following EBV-associated Infectious Mononucleosis
RecruitingPhase 2
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
Post-acute Sequelae of COVID-19, Long COVID
Enrolling by invitation
Fareon Open Label Device Clinical Trial
Cognitive Dysfunction, Acquired Brain Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Kinesiotaping and Conventional Physiotherapy in people with Post-COVID-19 Syndrome and Back Pain, run by Medipol University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Intensity assessed by Visual Analogue Scale (VAS) (time frame: Baseline (Pre-treatment) and Day 10 (Post-treatment)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2026.